Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Simon Amy. Officer active across 1 company, notably Beam Therapeutics Inc.. In total, 15 filings have been published. Breakdown: 0 buy · 10 sells. Total volume traded: €1.1m. History available since 31 March 2023. The latest transaction was disclosed on 27 July 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Simon Amy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations15 total
16,667 shares@ US$25.7417Common StockSEC:0001193125-26-323640:0
373 sharesCommon StockSEC:0001193125-26-294478:0
6,700 shares@ US$24.5819.6% of flowCommon StockSEC:0001193125-26-144080:0
31,750 shares0Common StockSEC:0001193125-26-140515:0
12,500 shares0Common StockSEC:0001193125-26-002422:0
374 shares@ US$16.94230.7% of flowCommon StockSEC:0000950170-25-094002:0
9,566 shares@ US$18.350627.9% of flowCommon StockSEC:0000950170-25-050852:0
27,500 shares0Common StockSEC:0000950170-25-049765:0
502 shares@ US$23.761.9% of flowCommon StockSEC:0000950170-24-081492:0
7,157 shares@ US$32.1336.7% of flowCommon StockSEC:0000950170-24-041441:0
27,500 shares0Common StockSEC:0000950170-24-040152:0
3,448 shares@ US$18.7010.5% of flowCommon StockSEC:0000950170-23-057499:0
391 shares@ US$30.481.9% of flowCommon StockSEC:0000950170-23-040574:0
4,445 shares@ US$30.3121.2% of flowCommon StockSEC:0000899243-23-010816:0
20,000 shares0Common StockSEC:0000899243-23-010134:0
About Simon Amy
Simon Amy is Chief Medical Officer at Beam Therapeutics Inc. (XNAS). Across 10 filings recorded, the 10 sampled filings, all sales, cover the period from 2023-03-31 to 2026-07-02 and total 583211 EUR in sell transactions, with no purchases reported.